Abbvie expects to bring endometriosis drug to FDA in 2017 By: MarketWatch February 10, 2016 at 11:18 AM EST AbbVie said the endometriosis drug it’s developing with Neurocrine Bioscience will go to the FDA next year. Read More >> Related Stocks: AbbVie Neurocrine Bioscienc